Myosotis Investments B.V. is a privately held Dutch investment company founded in 2024 that provides financial and business support to life science enterprises, with a preference for those active in molecular diagnostics. Based in Zeist, the Netherlands, the firm aims to guide portfolio companies toward meaningful, lasting improvements in healthcare and quality of life. It focuses on backing innovations in healthcare through strategic funding and business development guidance.
No recent news for this company.